Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1962 2
1963 1
1966 1
1967 1
1969 3
1970 1
1971 1
1978 1
1979 1
1980 2
1982 5
1983 6
1984 4
1985 4
1986 3
1987 9
1988 10
1989 8
1990 8
1991 11
1992 9
1993 11
1994 17
1995 6
1996 12
1997 9
1998 4
1999 10
2000 10
2001 7
2002 9
2003 14
2004 7
2005 12
2006 9
2007 6
2008 9
2009 11
2010 9
2011 17
2012 14
2013 18
2014 22
2015 19
2016 22
2017 20
2018 18
2019 14
2020 15
2021 19
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

444 results
Results by year
Filters applied: . Clear all
Page 1
Towards an integrated model of bacterial conjugation.
Cabezón E, Ripoll-Rozada J, Peña A, de la Cruz F, Arechaga I. Cabezón E, et al. Among authors: de la cruz f. FEMS Microbiol Rev. 2015 Jan;39(1):81-95. doi: 10.1111/1574-6976.12085. Epub 2014 Dec 4. FEMS Microbiol Rev. 2015. PMID: 25154632 Free article. Review.
Mobility of plasmids.
Smillie C, Garcillán-Barcia MP, Francia MV, Rocha EP, de la Cruz F. Smillie C, et al. Among authors: de la cruz f. Microbiol Mol Biol Rev. 2010 Sep;74(3):434-52. doi: 10.1128/MMBR.00020-10. Microbiol Mol Biol Rev. 2010. PMID: 20805406 Free PMC article. Review.
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.
Kalakonda N, Maerevoet M, Cavallo F, Follows G, Goy A, Vermaat JSP, Casasnovas O, Hamad N, Zijlstra JM, Bakhshi S, Bouabdallah R, Choquet S, Gurion R, Hill B, Jaeger U, Sancho JM, Schuster M, Thieblemont C, De la Cruz F, Egyed M, Mishra S, Offner F, Vassilakopoulos TP, Warzocha K, McCarthy D, Ma X, Corona K, Saint-Martin JR, Chang H, Landesman Y, Joshi A, Wang H, Shah J, Shacham S, Kauffman M, Van Den Neste E, Canales MA. Kalakonda N, et al. Among authors: de la cruz f. Lancet Haematol. 2020 Jul;7(7):e511-e522. doi: 10.1016/S2352-3026(20)30120-4. Lancet Haematol. 2020. PMID: 32589977 Free article. Clinical Trial.
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.
Parikh AR, Leshchiner I, Elagina L, Goyal L, Levovitz C, Siravegna G, Livitz D, Rhrissorrakrai K, Martin EE, Van Seventer EE, Hanna M, Slowik K, Utro F, Pinto CJ, Wong A, Danysh BP, de la Cruz FF, Fetter IJ, Nadres B, Shahzade HA, Allen JN, Blaszkowsky LS, Clark JW, Giantonio B, Murphy JE, Nipp RD, Roeland E, Ryan DP, Weekes CD, Kwak EL, Faris JE, Wo JY, Aguet F, Dey-Guha I, Hazar-Rethinam M, Dias-Santagata D, Ting DT, Zhu AX, Hong TS, Golub TR, Iafrate AJ, Adalsteinsson VA, Bardelli A, Parida L, Juric D, Getz G, Corcoran RB. Parikh AR, et al. Among authors: de la cruz ff. Nat Med. 2019 Sep;25(9):1415-1421. doi: 10.1038/s41591-019-0561-9. Epub 2019 Sep 9. Nat Med. 2019. PMID: 31501609 Free PMC article.
Nanobiotechnology.
de la Cruz F, Gadd GM. de la Cruz F, et al. Curr Opin Biotechnol. 2012 Aug;23(4):501-2. doi: 10.1016/j.copbio.2012.05.002. Epub 2012 Jun 7. Curr Opin Biotechnol. 2012. PMID: 22683114 Free article. No abstract available.
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group).
Garcia-Sanz R, Sureda A, de la Cruz F, Canales M, Gonzalez AP, Pinana JL, Rodriguez A, Gutierrez A, Domingo-Domenech E, Sanchez-Gonzalez B, Rodriguez G, Lopez J, Moreno M, Rodriguez-Salazar MJ, Jimenez-Cabrera S, Caballero MD, Martinez C. Garcia-Sanz R, et al. Among authors: de la cruz f. Ann Oncol. 2019 Apr 1;30(4):612-620. doi: 10.1093/annonc/mdz009. Ann Oncol. 2019. PMID: 30657848 Free article. Clinical Trial.
The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO, Pacheco-Herrero M, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Villegas-Rojas MM, Harrington CR, de la Cruz F, Garcés-Ramírez L, Luna-Muñoz J. Soto-Rojas LO, et al. Among authors: de la cruz f. Int J Mol Sci. 2021 Feb 18;22(4):2022. doi: 10.3390/ijms22042022. Int J Mol Sci. 2021. PMID: 33670754 Free PMC article. Review.
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Giné E, de la Cruz F, Jiménez Ubieto A, López Jimenez J, Martín García-Sancho A, Terol MJ, González Barca E, Casanova M, de la Fuente A, Marín-Niebla A, Muntañola A, González-López TJ, Aymerich M, Setoain X, Cortés-Romera M, Rotger A, Rodríguez S, Medina Herrera A, García Sanz R, Nadeu F, Beà S, Campo E, López-Guillermo A. Giné E, et al. Among authors: de la cruz f. J Clin Oncol. 2022 Apr 10;40(11):1196-1205. doi: 10.1200/JCO.21.02321. Epub 2022 Jan 14. J Clin Oncol. 2022. PMID: 35030036 Free PMC article. Clinical Trial.
[Sport dermatoses].
Kolbach R M, Cossio T ML, Sáenz de Santa María P ML, Carreño O N, de la Cruz F C, Fajre W X. Kolbach R M, et al. Among authors: de la cruz f c. Rev Med Chil. 2008 Feb;136(2):249-55. Epub 2008 May 7. Rev Med Chil. 2008. PMID: 18483681 Free article. Review. Spanish.
444 results